Transdermal scopolamine delivery system (TRANSDERM-V) and acute angle-closure glaucoma
Related Experiment Videos
Abstract:
A 58-year-old woman developed unilateral acute angle-closure glaucoma four days after the application of a patch of transdermal scopolamine delivery system (TRANSDERM-V).